arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Onconetix, Inc.

ONCO

$0.91 ▼ -0.05 (-5.47%) at close

22 Visible periods

27 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Onconetix, Inc. shows weak fundamentals, weighed down by Interest Coverage and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap —

Dividend Yield —

Revenue Growth -78.9% ↘

Op. Margin None

ROIC -68.8%

FCF / Share $-3.38

Trailing P/E —

Price / Book 0.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$21.46K

↓ -78.9% —

Net Income Profit after all expenses

$-4.21M

↑ +50.7% —

FCF / Share Free cash flow per share

$-3.38

↓ -2968.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Interest CoverageInterest Coverage of -23.30x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.69x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↑

Dividend History

Dividend / share · sourced from SEC filings

$1.23 Latest / share

FY 2020

FY 2021

$1.23

FY 2022

FY 2023

FY 2024

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-78.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1086%)	-57.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-817%)	-25.4% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-417%)	-84.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1161%)	-85.5% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1169%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	-1166.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-99.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-113.3% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-643.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-6.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-845.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-48.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-177.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-31675.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-14.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-19.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	61.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-24.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	50.7% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	23.1% Good ↑ Good Improving Year-over-year change in net income	23.1% Good ↑ Good Improving Year-over-year change in net income	23.1% Good ↑ Good Improving Year-over-year change in net income	-31.7% Weak ↑ Weak Improving Year-over-year change in net income	-290.6% Weak → Weak Stable Year-over-year change in net income	-290.6% Weak ↓ Weak Declining Year-over-year change in net income	-290.6% Weak ↓ Weak Declining Year-over-year change in net income	—	-37.5% Weak → Weak Stable Year-over-year change in net income	-37.5% Weak ↑ Weak Improving Year-over-year change in net income	-37.5% Weak ↑ Weak Improving Year-over-year change in net income	—	-535.6% Weak → Weak Stable Year-over-year change in net income	-535.6% Weak Weak Year-over-year change in net income	-535.6% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	-2968.0% Weak Weak Year-over-year change in free cash flow	—	—	—	53.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	15.4% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	—	-422.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2914%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	3.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	-129.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.50x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.17x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.03x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.19x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.56x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	0.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.56x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.24x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-68.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	-7.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	38.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	50.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	310.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-40.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-65.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-68.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-67.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-103.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-4.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-22.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-39.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-35.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-339%)	—	—	—	—	—	-32.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	31.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+107%)	51.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+244%)	—	-27.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-21.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-245%)	-14.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	—	-8.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-10.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-12.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-83.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-655%)	-12.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-183%)	-8.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	-6.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-5112.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-9.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-62.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-17.26x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-87.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-49.24x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-16.68x Weak Weak Operating income divided by interest expense Optimal: > 5x	-31.07x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—
Net Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$-29.14M	$-22.24M	$-18.61M	$-1.93M	—	—	—	—

📊 What does each share earn? 8 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.03	—	$0.22	$0.19	$0.01	—	$0.31	$0.03	$0.03	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-6.71	$12.58	$-6.25	$-4.76	$-0.53	$1.26K	$-2.93	$-0.64	$-0.50	$-50.84	$-0.31	$-0.43	$-0.18	$-0.16	$-0.27	$-0.36	—	$-0.42	$-0.40	$-0.29	—	—
Free Cash Flow per Share (USD)	$-3.38	—	$-2.26	$-2.48	$-0.11	—	—	—	$-0.24	—	—	—	$-0.28	—	—	—	—	—	$-0.23	$-0.12	—	—
Dividend per Share (USD)	—	—	—	—	—	—	—	—	—	—	$0.00	$-0.01	$1.03	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$4.26	—	—	—	—	—	$4.08	$-1.60	$-0.96	$-10.04	$0.57	$0.80	$1.24	$1.47	$1.75	$1.68	$1.50	$0.45	$0.82	$1.15	—	—
Tangible Book Value per Share (USD)	$0.56	—	—	—	—	—	$-3.17	$-4.15	$-4.02	$-155.33	$-0.43	$-0.29	$1.24	$1.47	$1.75	$1.68	$1.50	$0.45	$0.82	$1.15	—	—
Basic Weighted Avg Shares (shares)	628,528	—	1.41M	567,648	18.18M	—	1.31M	22.20M	22.15M	—	17.52M	15.91M	15.91M	—	14.34M	12.00M	—	—	3.20M	3.20M	—	—
Dividend Payout Ratio (%)	—	—	—	—	—	—	—	—	—	—	0.0% Excellent ↑ Excellent Improving Dividends paid as a percentage of earnings Optimal: 30-60%	2.3% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	-572.2% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$1.26M	$-3.07M	$-15.00M	$-11.76M	$-11.62M	$-17.34M	$-16.31M	$-18.57M	$-15.14M	$-11.35M	$-8.10M	$-729.10K	$19.66M	$22.34M	$25.62M	$20.46M	$16.30M	$1.44M	—	—	—	—
Total Equity (USD)	$11.75M	—	—	—	—	—	$33.91M	$-35.81M	$-21.53M	$-5.60M	$10.24M	$13.08M	$19.69M	$22.39M	$25.73M	$20.57M	$16.53M	$1.45M	$2.63M	$3.69M	$4.73M	$4.73M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$21.46K	$303.60K	$303.65K	$106.49K	$101.63K	$711.98K	$406.86K	$704.85K	$700.43K	—	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	—	$204.04K	$201.30K	$206.70K	$2.11K	$1.62K	$1.57K	$1.70K	—	—	—	$1.30K	$1.15K	$1.26K	$1.25K	$1.23K	—
Net Income, GAAP (USD)	$-4.21M	$5.67M	$-8.55M	$-8.55M	$-8.55M	$-29.44M	$-11.12M	$-11.12M	$-11.12M	$-22.35M	$-2.85M	$-2.85M	$-2.85M	—	$-2.07M	$-2.07M	$-2.07M	$-1.20M	$-325.78K	$-325.78K	$-325.78K	—
Operating Cash Flow (USD)	$-2.12M	$-3.09M	$-3.18M	$-1.41M	$-2.00M	$-917.65K	—	—	$-5.23M	$-4.31M	—	—	$-4.45M	$-2.80M	—	—	$-886.09K	$-674.40K	$-730.48K	$-382.81K	$-256.55K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Onconetix, Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare ONCO with peers